Quotes Denali Therapeutics Inc. Sao Paulo

Stocks

D2NL34

BRD2NLBDR008

Biotechnology & Medical Research

Market Closed - 14:04:39 2026-07-13 EDT 5-day change 1st Jan Change
27.06 BRL -1.31% Intraday chart for Denali Therapeutics Inc. -.--% +25.57%

Stock exchange

Performance

1 day-1.31%
3 months+31.61%
6 months+21.95%
Current year+25.57%
1 year+63.41%
3 years-28.34%

Volumes

markets
Daily volume
2
Estimated daily volume
2
Record volume 1
16,900
Record volume 2
16,900
Record volume 3
1,406
Capital turnover ratio
0
Float rotation
0

Basic data

Market Cap (BRL)
3,797,974,295
Market Cap (USD)
3,797,974,295
Net sales (USD)
0
Number of employees
503
Sales / Employee (USD)
0
Free-Float
90.03 %
Free-Float capitalization (BRL)
664,361,005
Free-Float capitalization (USD)
3,419,466,090

Indicators

Moving average 5 days
27.21
Moving average 20 days
22.68
Moving average 50 days
13.28
Moving average 100 days
22.86
Price spread / (MMA5)
+0.55%
Price spread / (MMA20)
-16.20%
Price spread / (MMA50)
-50.91%
Price spread / (MMA100)
-15.54%
STIM
RSI 9 days
68.58
RSI 14 days
68.59

Change 5-day change 1-year change 3-year change Capi.($)
-1.31%-.--%+63.41%-28.34% 3.8B
-0.25%-0.92%+49.47%+89.45% 68.13B
+1.21%+0.80%+46.29%+85.32% 63.6B
+1.31%-5.21%+37.52%+12.07% 25.57B
-0.25%-1.92%-10.72%+436.70% 26.6B
+0.33%-10.61%+1.95%-16.27% 25.52B
-6.09%-12.08%+226.11%+375.00% 18.23B
+1.18%-2.23%+30.87%-19.04% 19.69B
-1.49%-6.44%+0.78%+540.26% 15.16B
+4.12%+0.30%+52.03%+150.18% 13.54B
Average -0.12%-3.85%+49.77%+162.53% 27.98B
Weighted average by Cap. +0.13%-2.88%+45.47%+141.54%

Historical Quotes: Denali Therapeutics Inc.

DateOpeningHighLowCloseVolumeChange
Chart Denali Therapeutics Inc.

Price Extremes

Current year 19.44
Extreme 19.44
27.42
1 year 13.5
Extreme 13.5
27.42
3 years 13.48
Extreme 13.48
36.2
5 years 13.48
Extreme 13.48
40.04
10 years 13.48
Extreme 13.48
40.04

Monthly variations

Annual variations

2026+25.57%
2025-24.09%
2024-24.81%
2022+1.27%
  1. Stock Market
  2. Stocks
  3. DNLI Stock
  4. D2NL34 Stock
  5. Quotes Denali Therapeutics Inc.